D.E. Shaw & Co’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-338,754
| Closed | -$56M | – | 5586 |
|
|
2021
Q2 | $56M | Sell |
338,754
-129,805
| -28% | -$21.7M | 0.05% | 482 |
|
|
2021
Q1 | $71.8M | Buy |
+468,559
| New | +$63.6M | 0.07% | 341 |
|
|
2020
Q4 | – | Sell |
-18,416
| Closed | -$1.87M | – | 4271 |
|
|
2020
Q3 | $1.87M | Sell |
18,416
-33,275
| -64% | -$3.39M | ﹤0.01% | 2449 |
|
|
2020
Q2 | $5.03M | Buy |
51,691
+26,499
| +105% | +$2.47M | 0.01% | 1663 |
|
|
2020
Q1 | $2.09M | Buy |
+25,192
| New | +$2.46M | ﹤0.01% | 2129 |
|
|
2018
Q2 | – | Sell |
-14,158
| Closed | -$1.18M | – | 3966 |
|
|
2018
Q1 | $1.18M | Sell |
14,158
-11,804
| -45% | -$1.05M | ﹤0.01% | 2384 |
|
|
2017
Q4 | $2.36M | Buy |
25,962
+11,655
| +81% | +$969K | ﹤0.01% | 2029 |
|
|
2017
Q3 | $1.09M | Sell |
14,307
-31,009
| -68% | -$2.34M | ﹤0.01% | 2444 |
|
|
2017
Q2 | $3.4M | Sell |
45,316
-16,362
| -27% | -$1.13M | 0.01% | 1627 |
|
|
2017
Q1 | $4.02M | Buy |
61,678
+52,928
| +605% | +$3.12M | 0.01% | 1425 |
|
|
2016
Q4 | $482K | Sell |
8,750
-5,029
| -36% | -$276K | ﹤0.01% | 2877 |
|
|
2016
Q3 | $779K | Sell |
13,779
-108,929
| -89% | -$5.34M | ﹤0.01% | 2555 |
|
|
2016
Q2 | $5.12M | Buy |
+122,708
| New | +$5.65M | 0.01% | 1275 |
|
|
2016
Q1 | – | Sell |
-37,014
| Closed | -$1.68M | – | 3896 |
|
|
2015
Q4 | $1.68M | Buy |
+37,014
| New | +$1.56M | ﹤0.01% | 2269 |
|
|
2015
Q2 | – | Sell |
-10,462
| Closed | -$302K | – | 3934 |
|
|
2015
Q1 | $302K | Buy |
+10,462
| New | +$292K | ﹤0.01% | 3297 |
|
Other funds holding PRAH
D.E. Shaw & Co's PRAH Position: Q3 2021 in Review
D.E. Shaw & Co sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 338,754 shares — an estimated $56M sold.
D.E. Shaw & Co first reported a position in PRAH in Q1 2015 and held it in 15 quarters. The position peaked at $71.8M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- D.E. Shaw & Co reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- D.E. Shaw & Co sold 338,754 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $56M.
- D.E. Shaw & Co first reported a position in PRA Health Sciences, Inc. in Q1 2015 and held it in 15 quarters.
- D.E. Shaw & Co's PRA Health Sciences, Inc. position peaked at $71.8M in Q1 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.